COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

09/03/2018 - 13:01

FIT Biotech Oy Company release March 9, 2018 at 2.00 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]

MacroGenics to Present at Cowen Health Care Conference

09/03/2018 - 13:00

Rockville, MD, March 09, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2017 Results on March 15, 2018

09/03/2018 - 13:00

FREMONT, Calif., March 09, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:ST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]

Trillium Therapeutics Reports Annual 2017 Financial and Operating Results

09/03/2018 - 13:00

Presented evidence of clinical activity and good tolerability from both TTI-621 trials at ASH Received FDA clearance to proceed with second clinical CD47 program, TTI-622 Cash and marketable securities of $81.8 million [...]

ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights

09/03/2018 - 13:00

-- Phase III ADVOCATE trial of avacopan in treatment of ANCA vasculitis nears 75% of patient enrollment target as European Medicine Agency continues review process of Conditional Marketing Authorization application [...]

Anavex Life Sciences to Present at the 30th Annual ROTH Conference

09/03/2018 - 13:00

NEW YORK, March 09, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]

R1 RCM Reports Fourth Quarter and Full Year 2017 Results

09/03/2018 - 13:00

CHICAGO, March 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]

Solon Eiendom ASA : Extraordinary general meeting

09/03/2018 - 11:13

Solon Eiendom ASA (OSE: SOLON), held an extraordinary general meeting at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 09 March 2018. All proposals were resolved as presented in the notice convening the [...]

Fertin Pharma A/S is awarded another issued patent on one-layered compressed nicotine gum

09/03/2018 - 08:44

VEJLE, Denmark, March 09, 2018 (GLOBE NEWSWIRE) -- The market leading nicotine gum manufacturer, Fertin Pharma A/S, adds another milestone in the protection of compressed nicotine gum. While Fertin Pharma A/S has [...]

Proposed merger between Medical Prognosis Institute and Oncology Venture

09/03/2018 - 08:01

Hørsholm, Denmark - Medical Prognosis Institute A/S ("MPI") (Nasdaq First North Stockholm: MPI) and Oncology Venture Sweden AB (publ) ("Oncology Venture" or "OV") (AktieTorget: OV) today jointly announce that their [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

09/03/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 9 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock

09/03/2018 - 04:00

SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT ), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing [...]

Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2017 Financial Results

09/03/2018 - 03:07

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced that the company will report financial results for the three months ended December 31, 2017, before the opening of trading [...]

Pascal Announces Oversubscription of Financing

09/03/2018 - 02:35

VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSX [...]

Sorrento Therapeutics CEO Dr. Ji to Present at Roth Capital Partners 30th Annual Growth Stock Conference on 03/12/18

09/03/2018 - 00:16

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at Roth Capital Partners 30 th annual growth stock conference on 03/12/18 at 1 [...]

Xeris Pharmaceuticals, Inc. Completes $55 million In New Financing To Support Ready-To-Use Glucagon Development

09/03/2018 - 00:00

CHICAGO, IL, March 08, 2018 (GLOBE NEWSWIRE) -- CHICAGO, IL; March 8, 2018 (GLOBE NEWSWIRE) – Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to [...]

Alphatec Spine Disrupts Market with Acquisition of SafeOp Surgical, ~$50M Equity Financing, and Strategic Leadership Appointments

08/03/2018 - 23:26

Acquisition provides Alphatec most advanced automated neuromonitoring technology Private placement funded by senior leadership, new and existing investors Luiz Pimenta, MD, PhD, to assume role of Chief Medical Officer [...]

Alphatec Spine Reports Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 23:13

CARLSBAD, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives [...]

Immunovaccine Chief Medical Officer Dr. Gabriela Rosu to Present at the Oncology Meeting Innovations (OMI) Annual Summit on Hematologic Malignancies

08/03/2018 - 23:05

HALIFAX, Nova Scotia, March 08, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that its Chief Medical Officer, Gabriela Nicola Rosu, MD [...]